IQVIA Logo
Contact Us
hero bg-3233_Laboratory scientist working at lab with micropipette, and 96 well plate

Services

Discovery Sciences
Home / Services / Discovery Sciences

At IQVIA Laboratories, our approach to drug discovery combines deep scientific expertise, relentless curiosity and a commitment to help our customers go beyond traditional models. Our translation-focused approach anchors decisions to what matters most downstream—clinical success. We integrate comprehensive discovery and clinical data with AI-powered solutions to help customers understand disease biology, select the right target and modality, and make decisions faster and with greater confidence. 

 

IQVIA Laboratories provides services across the entire discovery continuum, from early target insight and validation to new approach methodologies (NAMs) and early safety testing. We help customers move through each phase with greater confidence, reducing risk and focusing on the most promising candidates. By uniting biology, chemistry and safety, we help you overcome challenges, expedite timelines and advance promising science. 

Our Drug Discovery Services

 

In an industry where failure is the norm, we bring a track record of success, with small molecule programs progressing from hit identification to candidate selection as quickly as 19 months. Our scientists bring cross-program insight and clinical context to help you de risk earlier and move the right molecules forward.
healthcare_molecule_monitor-mod
Design and Developability

 

We utilize our 20 years of expertise and a vast repository of preclinical and clinical data to optimize candidate design and progression.
healthcare_developability - efficacy - v2-mod
Disease Biology

 

Our therapeutic expertise enables us to quickly assess the effectiveness of drug action or target modulation in the right disease context.

  • Target validation and efficacy in advanced human-relevant cell models

  • Target engagement assessment

  • In vitro and fit-for-purpose in vivo studies

  • Translational technologies (in vivo imaging)
healthcare_therapeutics-modHuman Safety NAMs

 

Our new approach methodologies (NAMs) are designed to deliver scalable, reproducible results with increased human relevance. Our experts can recommend where NAMs can be effectively applied, reducing reliance on traditional animal models while maintaining scientific rigor.

  • Fit-for-purpose, context-relevant assays at scale

  • NAMs across discovery, preclinical and early clinical development

  • Advanced cell-based and in silico models for human predictivity

  • Assessment of key organ toxicities

  • Key organ system toxicities 

  • IND-enabling on-target and off-organ toxicity panels for biologics

Discovery that evolves as your science unfolds

 

At IQVIA, drug discovery is where science meets possibility. From initiation through execution, our approach delivers:

  • Decades of experience and an ecosystem of proven success
  • AI-powered solutions and automated workflows to improve efficiency
  • A customized approach tailored to your biology, modality and therapeutic goals. 

From molecule to medicine, we're here to help reduce risk and advance therapies that matter.

Get in touch to access our ecosystem

Related Services

card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Discovery Sciences
Learn more card-3259_man in laboratory with tablet for medical analysis
Protein Sciences
Learn more card-3234_Liquid drop from pipette to test tube
Antibody Libraries
Learn more card-3229_test tubes for testing
In Vitro Immunology
Learn more card-3259_man in laboratory with tablet for medical analysis
Additional Specialty Testing Services
Learn more card-3276_A medical scientist is preparing a pathological specimen for diagnosis
Discovery Science Specialty Testing Services
Learn more